Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This product is supplied strictly for laboratory research use only and is not intended for human consumption
[248] In April 2025, Eli Lilly, represented by Kirkland & Ellis and Walsh Pizzi O'Reilly Falanga, filed a series of lawsuits in federal courts in New Jersey and California against several telehealth and compounding pharmacy companies, including Willow Health Services, Henry Meds, Mochi Health, Fella Health, and Empower Clinic Services, alleging unfair competition, false advertising, and deceptive business practices related to the sale of unapproved compounded tirzepatide products marketed for weight loss
Attempting to inject any leftover medicine could result in an incomplete dose even though the Pen still has medicine left in it
However, an Eli Lilly study that identified chemical impurities in tirzepatide compounded with vitamin B12 shows that these are unapproved drugs with uncertain safety
4.Compliance with the customers' standards
Know the warning signs and seek care immediately if you develop symptoms
